Abstract
In previous studies, cystic fibrosis (CF) fibroblasts were demonstrated to be resistant to the cytotoxic effects of ouabain, dexamethasone, and the sex hormones, dihydrotestosterone, 17β-estradiol, and progesterone. We now show that CF fibroblasts also exhibit greatly increased resistance to the cytotoxic effects of exogenous dibutyryl cyclic AMP (cAMP), as well as to isoproterenol and theophylline, drugs which are known to increase endogenous levels of cAMP. CF cells were also shown to have normal amounts of [3H]cAMP binding to protein kinase as well as normal amounts of cAMP-stimulated protein kinase activity. Phosphodiesterase in CF cells was also found to be stimulated by cAMP to the same degree as in normal cells. These findings suggest that there is no detectable protein kinase deficiency in CF cells. CF cells thus appear to be unlike some cAMP-resistant mutants described by others which are defective in protein kinase activity and cAMP regulation of phosphodiesterase levels. The cross-resistance of CF fibroblasts to ouabain, steroid hormones, and cAMP may provide a unique opportunity to study the biochemical events involved in the metabolism of these drugs as well as the basic biochemical defect in a common human genetic disease.
Similar content being viewed by others
Literature cited
Epstein, J., and Breslow, J. L. (1977).Proc. Natl. Acad. Sci. U.S.A. 74:1676–1679.
Epstein, J., Breslow, J. L., and Davidson, R. L. (1977).Proc. Natl. Acad. Sci. U.S.A.,74:5642–5646.
Breslow, J. L., Epstein, J., and Fontaine, J. H. (1978).Cell 13:663–669.
Breslow, J. L., Epstein, J., Vayo, M. M., and Fontaine, J. H. (1977).Exp. Cell Res. 110:399–407.
Lelievre, L., Paraf, A., Charlemagne, D., and Sheppard, J. R. (1977).Exp. Cell Res. 104:191–197.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951).J. Biol. Chem. 193:265–275.
Insel, P. A., Bourne, H. R., Coffino, P., and Tomkins, G. M. (1975).Science 190:896–898.
Gilman, A. G. (1970).Proc. Natl. Acad. Sci. U.S.A. 67:305–312.
Beavo, J. A., Hardman, J. G., and Sutherland, E. W. (1970).J. Biol. Chem. 245:5649–5655.
Manganiello, V. C., and Breslow, J. (1974).Biochim. Biophys. Acta 362:509–520.
Appleman, M. M., Thompson, W. J., and Russell, T. R. (1973). InAdvances in Cyclic Nucleotide Research (eds.) Greengard, P., and Robison, G. A. (Raven Press, New York), Vol. 3, pp. 65–98.
Kuo, J. F., and Greengard, P. (1969).Proc. Natl. Acad. Sci. U.S.A. 64:1349–1355.
Erlichman, J., Rubin, C. S., and Rosen, O. M. (1973).J. Biol. Chem. 248:7607–7609.
Beavo, J. A., Bechtel, P. J., and Krebs, E. G. (1975). InAdvances in Cyclic Nucleotide Research (eds.) Drummond, P., Greengard, P., and Robison, G. A. (Raven Press, New York), Vol. 5, pp. 241–252.
Daniel, V., Litwack, G., and Tomkins, G. M. (1973).Proc. Natl. Acad. Sci. U.S.A. 70:76–79.
Coffino, P., Bourne, H. R., and Tomkins, G. M. (1975).J. Cell. Physiol. 85:603–610.
Bourne, H. R., Coffino, P., and Tomkins, G. M. (1975).J. Cell. Physiol. 85:611–620.
Buchwald, M. (1976).Proc. Natl. Acad. Sci. U.S.A. 73:2899–2903.
Bourne, H. R., Tomkins, G. M., and Dion, S. (1973).Science 181:952–954.
D'Armiento, M., Johnson, G. S., and Pastan, I. (1972).Proc. Natl. Acad. Sci. U.S.A. 69:459–462.
Manganiello, V., and Vaughan, M. (1972).Proc. Natl. Acad. Sci. U.S.A. 69:269–273.
Thompson, E. B., and Lippman, M. E. (1974).Metabolism 23:159–202.
Mankovitz, R., Buchwald, M., and Baker, R. M. (1974).Cell 3:221–226.
Lever, J. E., and Seegmiller, J. E. (1976).J. Cell. Physiol. 88:343–352.
Baxter, J. D., Harris, A. W., Tomkins, G. M., and Cohn, M. (1971).Science 171:189–191.
Sibley, C. H., and Tomkins, G. M. (1974).Cell 2:221–227.
Yamamoto, K. R., Gehring, U., Stampfer, M. R., and Sibley, C. H. (1976). InRecent Progress in Hormone Research (ed.) Greep, R. O. (Academic Press, New York), Vol. 32, pp. 3–32.
Bourgeois, S., and Newby, R. F. (1977).Cell 11:423–430.
Bourne, H. R., Coffino, P., and Tomkins, G. M. (1975).Science 187:750–752.
Granner, D. K. (1974).Nature 259:572–573.
Schaffer, L. D., Chenoweth, M., and Dunn, A. (1969).Biochim. Biophys. Acta 192:304–309.
Miller, T. B., Axton, J. H., and Park, C. R. (1971).J. Biol. Chem. 246:3672–3678.
Axton, J. H., Friedman, N., Wong, E. H., Brimaux, J. P., Corbin, J. D., and Park, C. R. (1972).J. Biol. Chem. 247:3579–3588.
Stellwagen, R. H. (1972).Biochem. Biophys. Res. Commun. 47:1144–1150.
Van Rijn, H., Bevers, M. M., Van Wijk, R., and Wicks, W. D. (1974).J. Biol. Chem. 60:181–191.
Lemaire, I., and Coffino, P. (1977).Cell 11:149–155.
Mommaerts, W. F. H. M., Illingworth, B., Pearson, C. M., Guillorey, R. J., and Seraydarian, K. (1959).Proc. Natl. Acad. Sci. U.S.A. 45:791–797.
Hug, G., Schubert, W. K., and Chuck, G. (1969).J. Clin. Invest. 48:704–715.
Huijing, F., and Fernandes, J. (1969).Am. J. Hum. Genet. 21:275–284.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Epstein, J., Breslow, J.L., Fitzsimmons, M.J. et al. Pleiotropic drug resistance in cystic fibrosis fibroblasts: Increased resistance to cyclic AMP. Somat Cell Mol Genet 4, 451–464 (1978). https://doi.org/10.1007/BF01538866
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01538866